Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

View source ↗

Summary

This clinical trial update reports ongoing recruitment for evaluating ustekinumab in patients with symptomatic stricturing Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stelara (ustekinumab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Crohn Disease, Stricture; Bowel | Status: RECRUITING